BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, Kim JM, Kim YI, Ryu KW, Kong SH, Kim HI, Jung HY, Kim YS, Zang DY, Cho JY, Park JO, Lim DH, Jung ES, Ahn HS, Kim HJ. Clinical practice guidelines for gastric cancer in Korea: an evidence-based approach. J Gastric Cancer. 2014;14:87-104. [PMID: 25061536 DOI: 10.5230/jgc.2014.14.2.87] [Cited by in Crossref: 119] [Cited by in F6Publishing: 88] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Carter GC, Kaltenboeck A, Ivanova J, Liepa AM, San Roman A, Koh M, Rajan N, Cheng R, Birnbaum HG, Kim JS, Bang YJ. Real-World Treatment Patterns among Patients with Advanced Gastric Cancer in South Korea. Cancer Res Treat 2017;49:578-87. [PMID: 27618820 DOI: 10.4143/crt.2016.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
2 Park JY, Kook MC, Eom BW, Yoon HM, Kim SJ, Rho JY, Kim SK, Kim YI, Cho SJ, Lee JY, Kim CG, Choi IJ, Kim YW, Ryu KW. Practical intraoperative pathologic evaluation of sentinel lymph nodes during sentinel node navigation surgery in gastric cancer patients - Proposal of the pathologic protocol for the upcoming SENORITA trial. Surg Oncol 2016;25:139-46. [PMID: 27566014 DOI: 10.1016/j.suronc.2016.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
3 Zhao F, Cho I, Cho GS, Chung JC. Effect of non-curative endoscopic submucosal dissection on short-term outcomes of subsequent surgery for early gastric cancer. Asian J Surg 2021:S1015-9584(21)00272-4. [PMID: 34053828 DOI: 10.1016/j.asjsur.2021.05.008] [Reference Citation Analysis]
4 Kwak DS, Min YW, Lee JH, Kang SH, Jang SH, Lee H, Min BH, Kim JJ, Kim KM, Sohn TS, Kim S. Outcomes of Endoscopic Submucosal Dissection for Early Gastric Cancer with Undifferentiated-Type Histology: A Clinical Simulation Using a Non-Selected Surgical Cohort. Gut Liver 2018;12:263-70. [PMID: 29271182 DOI: 10.5009/gnl17247] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
5 Zhang C, Zhang C, Wang Q, Li Z, Lin J, Wang H. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types. JAMA Netw Open 2020;3:e202950. [PMID: 32267515 DOI: 10.1001/jamanetworkopen.2020.2950] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 16.0] [Reference Citation Analysis]
6 Xin J, Wang S, Wang B, Wang J, Wang J, Zhang L, Xin B, Shen L, Zhang Z, Yao C. AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers. Int J Nanomedicine 2018;13:2017-36. [PMID: 29670347 DOI: 10.2147/IJN.S154054] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
7 Bang CS, Yang YJ, Lee JJ, Baik GH. Endoscopic Submucosal Dissection of Early Gastric Cancer with Mixed-Type Histology: A Systematic Review. Dig Dis Sci 2020;65:276-91. [PMID: 31367880 DOI: 10.1007/s10620-019-05761-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
8 Ryu WJ, Lee JE, Cho YH, Lee G, Seo MK, Lee SK, Hwang JH, Min DS, Noh SH, Paik S, Kim S, Cheong JH, Choi KY. A Therapeutic Strategy for Chemotherapy-Resistant Gastric Cancer via Destabilization of Both β-Catenin and RAS. Cancers (Basel) 2019;11:E496. [PMID: 30965636 DOI: 10.3390/cancers11040496] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bang CS, Ahn JY, Kim JH, Kim YI, Choi IJ, Shin WG. Establishing Machine Learning Models to Predict Curative Resection in Early Gastric Cancer with Undifferentiated Histology: Development and Usability Study. J Med Internet Res. 2021;23:e25053. [PMID: 33856358 DOI: 10.2196/25053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Lee J, Kim BW, Huh CW, Kim JS, Maeng LS. Endoscopic Factors that Can Predict Histological Ulcerations in Early Gastric Cancers. Clin Endosc 2020;53:328-33. [PMID: 31906605 DOI: 10.5946/ce.2019.133] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Sohn SH, Lee SH, Kim KO, Jang BI, Kim TN. Therapeutic outcomes of endoscopic submucosal dissection for early gastric cancer: single-center study. Eur J Gastroenterol Hepatol. 2017;29:61-67. [PMID: 27508325 DOI: 10.1097/meg.0000000000000718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kang DH, Choi CW, Kim HW, Park SB, Kim SJ, Nam HS, Ryu DG. Location characteristics of early gastric cancer treated with endoscopic submucosal dissection. Surg Endosc 2017;31:4673-9. [PMID: 28389793 DOI: 10.1007/s00464-017-5534-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
13 Choe WH, Kim JH, Park JH, Kim HU, Cho DH, Lee SP, Lee TY, Lee S, Sung IK, Park HS, Shim CS. Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis. Dig Dis Sci 2018;63:466-73. [DOI: 10.1007/s10620-017-4814-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Han JH, Kim M, Kim HJ, Jang SB, Bae SJ, Lee IK, Ryu D, Ha KT. Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil. Int J Mol Sci 2021;22:5406. [PMID: 34065602 DOI: 10.3390/ijms22105406] [Reference Citation Analysis]
15 Suh Y, Lee J, Woo H, Shin D, Kong S, Lee H, Shin A, Yang H. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. Cancer 2020;126:1929-39. [DOI: 10.1002/cncr.32753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
16 Cho J, Cha S, Kim HG, Lee TH, Cho JY, Ko WJ, Jin S, Park S. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a comparison study to surgery using propensity score-matched analysis. Surg Endosc 2016;30:3762-73. [DOI: 10.1007/s00464-015-4672-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
17 Okabe H, Hata H, Ueda S, Zaima M, Tokuka A, Yoshimura T, Ota S, Kinjo Y, Yoshimura K, Sakai Y; Kyoto University Surgical Oncology Group (KUSOG). A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03. J Surg Oncol 2016;113:36-41. [PMID: 26604064 DOI: 10.1002/jso.24096] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
18 Bang CS, Shin WG, Seo SI, Choi MH, Jang HJ, Park SW, Kae SH, Yang YJ, Shin SP, Baik GH, Kim HY. Effect of ilaprazole on the healing of endoscopic submucosal dissection-induced gastric ulcer: randomized-controlled, multicenter study. Surg Endosc 2019;33:1376-85. [PMID: 30167954 DOI: 10.1007/s00464-018-6412-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Mu J, Wang X, Dong L, Sun P. Curcumin derivative L6H4 inhibits proliferation and invasion of gastric cancer cell line BGC-823. J Cell Biochem 2019;120:1011-7. [PMID: 30242876 DOI: 10.1002/jcb.27542] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
20 Chung HW, Kim JH, Sung I, Lee S, Park HS, Shim CS, Bang HY, So Y, Lee EJ. FDG PET/CT to predict the curability of endoscopic resection for early gastric cancer. J Cancer Res Clin Oncol 2019;145:759-64. [DOI: 10.1007/s00432-018-02832-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Eom BW, Kim YW, Nam BH, Ryu KW, Jeong HY, Park YK, Lee YJ, Yang HK, Yu W, Yook JH, Song GA, Youn SJ, Kim HU, Noh SH, Park SB, Yang DH, Kim S. The Korean Gastric Cancer Cohort Study: Study Protocol and Brief Results of a Large-Scale Prospective Cohort Study. J Gastric Cancer 2016;16:182-90. [PMID: 27752396 DOI: 10.5230/jgc.2016.16.3.182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Li H, Chen L, Huo Z, Xi H, Cui J, Zhao X. Defining a Subgroup Treatable for Laparoscopic and Endoscopic Cooperative Surgery in Undifferentiated Early Gastric Cancer: the Role of Lymph Node Metastasis. J Gastrointest Surg 2015;19:1763-8. [PMID: 26224040 DOI: 10.1007/s11605-015-2897-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Okabe H, Tsunoda S, Obama K, Tanaka E, Hisamori S, Shinohara H, Sakai Y. Feasibility of Laparoscopic Radical Gastrectomy for Gastric Cancer of Clinical Stage II or Higher: Early Outcomes in a Phase II Study (KUGC04). Ann Surg Oncol 2016;23:516-23. [PMID: 27401443 DOI: 10.1245/s10434-016-5383-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
24 Eom BW, Joo J, Park B, Jo MJ, Choi SH, Cho SJ, Ryu KW, Kim YW, Kook MC. Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer. PLoS One 2016;11:e0159424. [PMID: 27482895 DOI: 10.1371/journal.pone.0159424] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
25 Kim Y, Kim YA, Kim CG, Ryu KW, Kim Y, Sim JA, Yun YH, Choi IJ. Serial intermediate-term quality of life comparison after endoscopic submucosal dissection versus surgery in early gastric cancer patients. Surg Endosc 2018;32:2114-22. [DOI: 10.1007/s00464-017-5909-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
26 Wang X, Chen Q, Huang X, Zou F, Fu Z, Chen Y, Li Y, Wang Z, Liu L. Effects of 17β-estradiol and tamoxifen on gastric cancer cell proliferation and apoptosis and ER-α36 expression. Oncol Lett 2017;13:57-62. [PMID: 28123522 DOI: 10.3892/ol.2016.5424] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
27 Koh J, Ock CY, Kim JW, Nam SK, Kwak Y, Yun S, Ahn SH, Park DJ, Kim HH, Kim WH, Lee HS. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Oncotarget 2017;8:26356-67. [PMID: 28412752 DOI: 10.18632/oncotarget.15465] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
28 Kim SY, Ko YS, Park J, Choi Y, Park JW, Kim Y, Pyo JS, Yoo YB, Lee JS, Lee BL. Forkhead Transcription Factor FOXO1 Inhibits Angiogenesis in Gastric Cancer in Relation to SIRT1. Cancer Res Treat 2016;48:345-54. [PMID: 25761483 DOI: 10.4143/crt.2014.247] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
29 Wang Y, Lei X, Liu Z, Shan F, Ying X, Li Z, Ji J. Short-term outcomes of laparoscopic versus open total gastrectomy after neoadjuvant chemotherapy: a cohort study using the propensity score matching method. J Gastrointest Oncol 2021;12:237-48. [PMID: 34012622 DOI: 10.21037/jgo-20-374] [Reference Citation Analysis]
30 Kim YI, Kim HS, Kook MC, Cho SJ, Lee JY, Kim CG, Ryu KW, Kim YW, Choi IJ. Discrepancy between Clinical and Final Pathological Evaluation Findings in Early Gastric Cancer Patients Treated with Endoscopic Submucosal Dissection. J Gastric Cancer 2016;16:34-42. [PMID: 27104025 DOI: 10.5230/jgc.2016.16.1.34] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
31 Zhou CM, Wang Y, Ye HT, Yan S, Ji M, Liu P, Yang JJ. Machine learning predicts lymph node metastasis of poorly differentiated-type intramucosal gastric cancer. Sci Rep 2021;11:1300. [PMID: 33446730 DOI: 10.1038/s41598-020-80582-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
32 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 17.7] [Reference Citation Analysis]
33 Jian Y, Zhao M, Cao J, Fan T, Bu W, Yang Y, Li W, Zhang W, Qiao Y, Wang J, Wen A. A Gastric Cancer Peptide GX1-Modified Nano-Lipid Carriers Encapsulating Paclitaxel: Design and Evaluation of Anti-Tumor Activity. Drug Des Devel Ther 2020;14:2355-70. [PMID: 32606603 DOI: 10.2147/DDDT.S233023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Cheng J, Wu J, Ye Y, Zhang C, Zhang Y, Wang Y. Extramural venous invasion detected by MDCT as an adverse imaging feature for predicting synchronous metastases in T4 gastric cancer. Acta Radiol 2017;58:387-93. [PMID: 27439402 DOI: 10.1177/0284185116658323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
35 Jeon J, Cheong JH. Clinical Implementation of Precision Medicine in Gastric Cancer. J Gastric Cancer 2019;19:235-53. [PMID: 31598369 DOI: 10.5230/jgc.2019.19.e25] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Marrelli D, Polom K, Neri A, Roviello F. Clinical impact of molecular classifications in gastric cancer. Updates Surg 2018;70:225-32. [PMID: 29796937 DOI: 10.1007/s13304-018-0546-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 You YH, Kim YM, Ahn DH. Beginner Surgeon's Initial Experience with Distal Subtotal Gastrectomy for Gastric Cancer Using a Minimally Invasive Approach. J Gastric Cancer 2015;15:270-7. [PMID: 26819806 DOI: 10.5230/jgc.2015.15.4.270] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Irino T, Takeuchi H, Terashima M, Wakai T, Kitagawa Y. Gastric Cancer in Asia: Unique Features and Management. Am Soc Clin Oncol Educ Book 2017;37:279-91. [PMID: 28561675 DOI: 10.1200/EDBK_175228] [Cited by in Crossref: 5] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
39 Li H, Huo ZB, Chen SB, Li H, Wu DC, Zhai TS, Xiao QH, Wang SX, Zhang LL. Feasibility study on expanded indication for endoscopic submucosal dissection of intramucosal poorly differentiated early gastric cancer. World J Gastroenterol. 2016;22:6736-6741. [PMID: 27547016 DOI: 10.3748/wjg.v22.i29.6736] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
40 Lim H, Lee IS, Lee JH, Park YS, Kang HJ, Na HK, Ahn JY, Kim DH, Choi KD, Song HJ, Lee GH, Jung HY, Kim JH, Kim BS, Yook JH, Kim BS. Clinical application of early gastric carcinoma with lymphoid stroma based on lymph node metastasis status. Gastric Cancer. 2017;20:793-801. [PMID: 28205059 DOI: 10.1007/s10120-017-0703-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
41 Yoon BK, Hwang N, Chun KH, Lee Y, Duarte TPM, Kim JW, Kim TH, Cheong JH, Fang S, Kim JW. Sp1-Induced FNBP1 Drives Rigorous 3D Cell Motility in EMT-Type Gastric Cancer Cells. Int J Mol Sci 2021;22:6784. [PMID: 34202606 DOI: 10.3390/ijms22136784] [Reference Citation Analysis]
42 Zhang Y, Liu S, Feng Q, Huang X, Wang X, Peng Y, Zhao Z, Liu Z. Perilaldehyde activates AMP-activated protein kinase to suppress the growth of gastric cancer via induction of autophagy. J Cell Biochem 2018. [PMID: 30378150 DOI: 10.1002/jcb.27491] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
43 Mihmanli M, Ilhan E, Idiz UO, Alemdar A, Demir U. Recent developments and innovations in gastric cancer. World J Gastroenterol 2016;22:4307-20. [PMID: 27158199 DOI: 10.3748/wjg.v22.i17.4307] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
44 Choi YY, Kim SJ, Choi CW, Kang DH, Kim HW, Park SB, Nam HS. Risk Factors of Submucosal or Lymphovascular Invasion in Early Gastric Cancer <2 cm. Medicine (Baltimore) 2016;95:e3822. [PMID: 27258528 DOI: 10.1097/MD.0000000000003822] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
45 Lee JH, Min YW, Lee JH, Kim ER, Lee H, Min BH, Kim JJ, Jang KT, Kim KM, Park CK. Diagnostic group classifications of gastric neoplasms by endoscopic resection criteria before and after treatment: real-world experience. Surg Endosc 2016;30:3987-93. [PMID: 26694184 DOI: 10.1007/s00464-015-4710-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
46 Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach. J Gastric Cancer 2019;19:1-48. [PMID: 30944757 DOI: 10.5230/jgc.2019.19.e8] [Cited by in Crossref: 103] [Cited by in F6Publishing: 87] [Article Influence: 51.5] [Reference Citation Analysis]
47 Shetty NP, Prabhakaran M, Srivastava AK. Pleiotropic nature of curcumin in targeting multiple apoptotic-mediated factors and related strategies to treat gastric cancer: A review. Phytother Res 2021. [PMID: 34028111 DOI: 10.1002/ptr.7158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
48 Nam HS, Kim HW, Choi CW, Kang DH, Park SB, Kim SJ, Choi JS. Characteristics of overlooked synchronous gastric epithelial neoplasia after endoscopic submucosal dissection. Medicine (Baltimore) 2018;97:e12536. [PMID: 30278545 DOI: 10.1097/MD.0000000000012536] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
49 Roh CK, Choi S, Seo WJ, Cho M, Choi YY, Son T, Hyung WJ, Kim HI. Comparison of surgical outcomes between integrated robotic and conventional laparoscopic surgery for distal gastrectomy: a propensity score matching analysis. Sci Rep 2020;10:485. [PMID: 31949219 DOI: 10.1038/s41598-020-57413-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
50 Degiuli M, De Manzoni G, Di Leo A, D'Ugo D, Galasso E, Marrelli D, Petrioli R, Polom K, Roviello F, Santullo F, Morino M. Gastric cancer: Current status of lymph node dissection. World J Gastroenterol. 2016;22:2875-2893. [PMID: 26973384 DOI: 10.3748/wjg.v22.i10.2875] [Cited by in CrossRef: 53] [Cited by in F6Publishing: 35] [Article Influence: 13.3] [Reference Citation Analysis]
51 Shen J, Ma X, Yang J, Zhang JP. Digestive tract reconstruction options after laparoscopic gastrectomy for gastric cancer. World J Gastrointest Oncol 2020;12:21-36. [PMID: 31966911 DOI: 10.4251/wjgo.v12.i1.21] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Bang CS, Baik GH. Pitfalls in the Interpretation of Publications about Endoscopic Submucosal Dissection of Early Gastric Cancer with Undifferentiated-Type Histology. Clin Endosc 2019;52:30-5. [PMID: 30650945 DOI: 10.5946/ce.2018.158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
53 Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, Nam HS. Clinical outcomes of endoscopic submucosa dissection for high-grade dysplasia from endoscopic forceps biopsy. Gastric Cancer 2017;20:671-8. [PMID: 27822683 DOI: 10.1007/s10120-016-0665-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
54 Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, Nam HS. Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia. Medicine (Baltimore). 2018;97:e11802. [PMID: 30113468 DOI: 10.1097/md.0000000000011802] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Li H, Feng LQ, Bian YY, Yang LL, Liu DX, Huo ZB, Zeng L. Comparison of endoscopic submucosal dissection with surgical gastrectomy for early gastric cancer: An updated meta-analysis. World J Gastrointest Oncol 2019;11:161-71. [PMID: 30788042 DOI: 10.4251/wjgo.v11.i2.161] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
56 Ryu DG, Choi CW, Kim SJ, Kang DH, Kim HW, Park SB, Nam HS. Possible indication of endoscopic resection in undifferentiated early gastric cancer. Sci Rep 2019;9:16869. [PMID: 31728024 DOI: 10.1038/s41598-019-53374-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
57 You X, Wang Y, Wu J, Liu Q, Chen D, Tang D, Wang D. Aberrant Cytokeratin 20 mRNA Expression in Peripheral Blood and Lymph Nodes Indicates Micrometastasis and Poor Prognosis in Patients With Gastric Carcinoma. Technol Cancer Res Treat 2019;18:1533033819832856. [PMID: 30827194 DOI: 10.1177/1533033819832856] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Zhang H, Li L, Yuan C, Wang C, Gao T, Zheng Z. MiR-489 inhibited the development of gastric cancer via regulating HDAC7 and PI3K/AKT pathway. World J Surg Oncol 2020;18:73. [PMID: 32284070 DOI: 10.1186/s12957-020-01846-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
59 Chen X, Eads JR, Ammori JB, Kumar AM, Biswas T, Dorth JA. Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach? Curr Oncol Rep 2015;17:18. [PMID: 25708803 DOI: 10.1007/s11912-015-0442-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Yang SY, Roh KH, Kim YN, Cho M, Lim SH, Son T, Hyung WJ, Kim HI. Surgical Outcomes After Open, Laparoscopic, and Robotic Gastrectomy for Gastric Cancer. Ann Surg Oncol 2017;24:1770-7. [PMID: 28357674 DOI: 10.1245/s10434-017-5851-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 34] [Article Influence: 12.8] [Reference Citation Analysis]
61 Ryu DG, Choi CW, Kang DH, Kim HW, Park SB, Kim SJ, Nam HS. Predictive factors to diagnosis undifferentiated early gastric cancer after endoscopic submucosal dissection. Medicine (Baltimore) 2017;96:e8044. [PMID: 28885374 DOI: 10.1097/MD.0000000000008044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
62 Marrelli D, Ferrara F, Giacopuzzi S, Morgagni P, Di Leo A, De Franco L, Pedrazzani C, Saragoni L, De Manzoni G, Roviello F. Incidence and Prognostic Value of Metastases to "Posterior" and Para-aortic Lymph Nodes in Resectable Gastric Cancer. Ann Surg Oncol 2017;24:2273-80. [PMID: 28405772 DOI: 10.1245/s10434-017-5857-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Zhu SX, Tong XZ, Zhang S. Expression of miR-711 and mechanism of proliferation and apoptosis in human gastric carcinoma. Oncol Lett 2017;14:4505-10. [PMID: 29085447 DOI: 10.3892/ol.2017.6777] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
64 Hu X, Chen L, Du Y, Fan B, Bu Z, Wang X, Ye Y, Zhang Z, Xiao G, Li F, He Q, Li G, Shen X, Xiong B, Zhu L, Liu J, Liu L, Wu T, Zhou J, Zhang J, Zhao G, Wang X, Liang P, Wang X, Zhang Y, Wu X, Zhang J, Ji X, Zong X, Fu T, Jia Z, Ji J. Postoperative chemotherapy with S-1 plus oxaliplatin versus S-1 alone in locally advanced gastric cancer (RESCUE-GC study): a protocol for a phase III randomized controlled trial. Chin J Cancer Res. 2017;29:144-148. [PMID: 28536493 DOI: 10.21147/j.issn.1000-9604.2017.02.07] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
65 Macalindong SS, Kim KH, Nam BH, Ryu KW, Kubo N, Kim JY, Eom BW, Yoon HM, Kook MC, Choi IJ, Kim YW. Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center. BMC Cancer. 2018;18:73. [PMID: 29329569 DOI: 10.1186/s12885-017-3872-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
66 Kim SJ, Choi CW, Nam HS, Kang DH, Kim HW, Park SB, Ryu DG. Factors associated with conversion to snare resection during gastric endoscopic submucosal dissection. Surg Endosc 2020;34:1585-91. [DOI: 10.1007/s00464-019-06918-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Karavokyros I, Michalinos A. Favoring D2-Lymphadenectomy in Gastric Cancer. Front Surg 2018;5:42. [PMID: 29930941 DOI: 10.3389/fsurg.2018.00042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
68 Mogal H, Fields R, Maithel SK, Votanopoulos K. In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection-D1 Versus D2 Versus D3? Ann Surg Oncol. 2019;26:2912-2932. [PMID: 31076930 DOI: 10.1245/s10434-019-07417-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
69 Yang F, Li A, Liu H, Zhang H. Gastric cancer combination therapy: synthesis of a hyaluronic acid and cisplatin containing lipid prodrug coloaded with sorafenib in a nanoparticulate system to exhibit enhanced anticancer efficacy and reduced toxicity. Drug Des Devel Ther 2018;12:3321-33. [PMID: 30323564 DOI: 10.2147/DDDT.S176879] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
70 Jang SH, Jung YJ, Kim MG, Kwon SJ. The Prognostic Significance of Compliance with Postoperative Adjuvant Chemotherapy in Patients with Stage III Gastric Cancer: an Observational Study. J Gastric Cancer. 2018;18:48-57. [PMID: 29629220 DOI: 10.5230/jgc.2018.18.e4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
71 Bang CS, Choi JH, Yang YJ, Lee JJ, Baik GH. Endoscopic submucosal dissection of early gastric cancer with mixed-type histology: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e13838. [PMID: 30572552 DOI: 10.1097/MD.0000000000013838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
72 Yang Q, Feng S, Liu H, Zhang X, Cao J, Zhu Y, Zheng H, Song H. Clinicopathological features and lymph node metastasis risk in early gastric cancer with WHO criteria in China: 304 cases analysis. Ann Diagn Pathol 2021;50:151652. [PMID: 33157382 DOI: 10.1016/j.anndiagpath.2020.151652] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Park HS, Kwon WS, Park S, Jo E, Lim SJ, Lee CK, Lee JB, Jung M, Kim HS, Beom SH, Park JY, Kim TS, Chung HC, Rha SY. Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer. J Immunother Cancer 2019;7:268. [PMID: 31639056 DOI: 10.1186/s40425-019-0708-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
74 Huang RJ, Choi AY, Truong CD, Yeh MM, Hwang JH. Diagnosis and Management of Gastric Intestinal Metaplasia: Current Status and Future Directions. Gut Liver. 2019;13:596-603. [PMID: 31394893 DOI: 10.5009/gnl19181] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 12.0] [Reference Citation Analysis]
75 Zurleni T, Gjoni E, Altomare M, Rausei S. Conversion surgery for gastric cancer patients: A review. World J Gastrointest Oncol 2018;10:398-409. [PMID: 30487951 DOI: 10.4251/wjgo.v10.i11.398] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
76 Lee KE, Lim KH. Differences in Factors Affecting the Quality of Life Over Time After the Gastrectomy in Patients With Stage I Gastric Cancer. Gastroenterol Nurs 2020;43:241-8. [PMID: 32487956 DOI: 10.1097/SGA.0000000000000416] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
77 Kim JW, Kim JG, Kang BW, Chung IJ, Hong YS, Kim TY, Song HS, Lee KH, Zang DY, Ko YH, Song EK, Baek JH, Koo DH, Oh SY, Cho H, Lee KW. Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer. Cancer Res Treat 2019;51:223-39. [PMID: 30584995 DOI: 10.4143/crt.2018.073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
78 Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol. 2019;30:19-33. [PMID: 30475956 DOI: 10.1093/annonc/mdy502] [Cited by in Crossref: 71] [Cited by in F6Publishing: 54] [Article Influence: 71.0] [Reference Citation Analysis]
79 Reddavid R, Sofia S, Chiaro P, Colli F, Trapani R, Esposito L, Solej M, Degiuli M. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake? World J Gastroenterol. 2018;24:274-289. [PMID: 29375213 DOI: 10.3748/wjg.v24.i2.274] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 24] [Article Influence: 10.3] [Reference Citation Analysis]
80 Lee H, Lee JH. Expanding indications of endoscopic submucosal dissection for early gastric cancer: hope or hype? Gut Liver. 2015;9:135-136. [PMID: 25720997 DOI: 10.5009/gnl15008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
81 Roh CK, Choi S, Seo WJ, Cho M, Kim HI, Lee SK, Lim JS, Hyung WJ. Incidence and treatment outcomes of leakage after gastrectomy for gastric cancer: Experience of 14,075 patients from a large volume centre. Eur J Surg Oncol 2021;47:2304-12. [PMID: 33663943 DOI: 10.1016/j.ejso.2021.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Degiuli M, Reddavid R, Tomatis M, Ponti A, Morino M, Sasako M; of the Italian Gastric Cancer Study Group (IGCSG). D2 dissection improves disease-specific survival in advanced gastric cancer patients: 15-year follow-up results of the Italian Gastric Cancer Study Group D1 versus D2 randomised controlled trial. Eur J Cancer 2021;150:10-22. [PMID: 33887514 DOI: 10.1016/j.ejca.2021.03.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
83 Park HK, Lee KY, Yoo MW, Hwang TS, Han HS. Mixed Carcinoma as an Independent Prognostic Factor in Submucosal Invasive Gastric Carcinoma. J Korean Med Sci 2016;31:866-72. [PMID: 27247494 DOI: 10.3346/jkms.2016.31.6.866] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
84 Guner A, Kim SY, Yu JE, Min IK, Roh YH, Roh C, Seo WJ, Cho M, Choi S, Choi YY, Son T, Cheong JH, Hyung WJ, Noh SH, Kim HI. Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex. Ann Surg Oncol 2018;25:3239-47. [PMID: 30069658 DOI: 10.1245/s10434-018-6684-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
85 Bang CS, Park JM, Baik GH, Park JJ, Joo MK, Jang JY, Jeon SW, Choi SC, Sung JK, Cho KB. Therapeutic Outcomes of Endoscopic Resection of Early Gastric Cancer with Undifferentiated-Type Histology: A Korean ESD Registry Database Analysis. Clin Endosc. 2017;50:569-577. [PMID: 28743132 DOI: 10.5946/ce.2017.017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
86 Barchi LC, Ramos MFKP, Dias AR, Andreollo NA, Weston AC, LourenÇo LG, Malheiros CA, Kassab P, Zilberstein B, Ferraz ÁAB, Charruf AZ, Brandalise A, Silva AMD, Alves B, Marins CAM, Leite CV, Bresciani CJC, Szor D, Mucerino DR; Consensus. II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION. Arq Bras Cir Dig 2020;33:e1514. [PMID: 32844884 DOI: 10.1590/0102-672020190001e1514] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Kano M, Hayano K, Hayashi H, Hanari N, Gunji H, Toyozumi T, Murakami K, Uesato M, Ota S, Matsubara H. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis. Ann Surg Oncol 2019;26:1805-13. [PMID: 30977014 DOI: 10.1245/s10434-019-07299-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
88 Liang H, Deng J. Evaluation of rational extent lymphadenectomy for local advanced gastric cancer. Chin J Cancer Res. 2016;28:397-403. [PMID: 27647967 DOI: 10.21147/j.issn.1000-9604.2016.04.02] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]